MeSH tree: D12.776.826.750
Polycystic ovarian syndrome, or PCOS, can cause a range of symptoms, including disrupted menstrual cycles, abdominal obesity, cardiovascular disease, and type 2 diabetes. It's also one of the biggest causes of infertility—in ...
Apr 18, 2023
0
82
Like the better-known prostate-specific antigen (PSA), prostate-specific membrane antigen (PSMA) is a biomarker that can tell physicians much about a patient's metastatic prostate cancer. PSMA is a protein on the cell surface ...
Apr 10, 2023
0
88
New research indicates that for patients with breast cancer, the cancer's stage and receptor status can help clinicians predict whether and when cancer might recur after initial treatment. The findings are published by in ...
Mar 6, 2023
0
38
After six years of painful injections, Stephanie Walker has had enough.
Feb 8, 2023
0
216
Chronic stress can differentially change the neuronal structure and function in the brain, leading to anxiety disorders and other neuropsychiatric illness. Now, researchers may understand how the different change occurs.
Dec 2, 2022
0
88
A single drug compound simultaneously attacks hard-to-treat prostate cancer on several fronts, according to a new study in mice and human cells. It triggers immune cells to attack, helps the immune cells penetrate the tumor, ...
Nov 23, 2022
0
106
UT Southwestern researchers have identified a causative signaling pathway in breast cancer, providing potential new targets for treatment of the most common type of cancer in women. The findings, published in Science Advances, ...
Nov 1, 2022
0
56
Stopping prostate cancer cells from morphing into other cell types can overcome the resistance they develop to widely prescribed therapies, a study led by UT Southwestern scientists suggests. The findings, published in Nature ...
Oct 18, 2022
0
103
Finding valuable therapeutic interventions for prostate cancer has long guided the research of Dr. Feng Yang's lab at Baylor College of Medicine. In a study published in the Proceedings of the National Academy of Sciences, ...
Oct 17, 2022
0
117
A multi-center analysis of patients with invasive lobular carcinoma, or ILC—the second most common histological subtype of invasive breast cancer in the U.S.—showed that, despite its prevalence, ILC is detected later and ...
Oct 14, 2022
0
60
